## Variants and diseases

### [Relational list using ClinVar](https://www.ncbi.nlm.nih.gov/clinvar/)

|Disease|Gene|Variants|
|-------|----|--------|
|Hemochromatosis|HJV|NM_213653.3:c.959G>T|
|Thalassemia|HBB|NM_000518.5:c.113A>G|
|Haemophilia|F8|NM_000132.3:c.4379del|
|Cystic Fibrosis|EP300|NM_001429.4:c.4763T>C|
|Tay sachs disease|HEXA|NM_000520.6:c.1385A>T|
|Fragile X syndrome|FMR1|NM_002024.6:c.80C>A (CGG triplet repeat expansion??)|
|Huntington's disease|PRNP|NC_000020.11:g.4699813T>C|


### [Relational list using ClinGen](https://clinicalgenome.org/)
|Gene|Gene name|Chromosomal location|Gene product|Disease|
|----|---------|--------------------|------------|-------|
|CFTR|CF transmembrane conductance regulator|7q31.2|epithelial ion channel, transport of chloride ions across the cell membrane|Cystic fibrosis|
|CYBB|cytochrome b-245 beta chain|Xp21.1-p11.4|Critical component of the membrane-bound oxidase of phagocytes that generates superoxide|granulomatous disease|
|HJV|hemojuvelin BMP co-receptor|1q21.1|Acts as a bone morphogenetic protein (BMP) coreceptor|hemochromatosis type 2A|
|CDKN2A|cyclin dependent kinase inhibitor 2A|9p21.3|Acts as a negative regulator of the proliferation of normal cells by interacting strongly with CDK4 and CDK6|melanoma-pancreatic cancer syndrome|
|KRAS|KRAS proto-oncogene, GTPase|12p12.1|Ras proteins bind GDP/GTP and possess intrinsic GTPase activity|Noonan syndrome|
|TP53|tumor protein p53|17p13.1|Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type|Li-Fraumeni syndrome 1|
|FMR1|	FMRP translational regulator 1|	Xq27.3|	Multifunctional polyribosome-associated RNA-binding protein that plays a central role in neuronal development and synaptic plasticity	|Fragile X syndrome|
